Figure 6From: Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK Change in days off work pre- and post-BOTOX in chronic migraine sufferers. Back to article page